Copyright
©The Author(s) 2021.
World J Stem Cells. Apr 26, 2021; 13(4): 317-330
Published online Apr 26, 2021. doi: 10.4252/wjsc.v13.i4.317
Published online Apr 26, 2021. doi: 10.4252/wjsc.v13.i4.317
Figure 2 Hypoxia promotes cell cycle progression in human placenta-derived mesenchymal stem cells.
A: Cell cycle phase distribution of human placenta-derived mesenchymal stem cells (hP-MSCs) cultured under hypoxia and normoxia for 48 h and assayed by flow cytometry; B: Graph of the cell cycle distribution. Data are means ± SD (n = 3); Student’s t-test; C: Western blotting of cyclin E1, cyclin A2, CDK2, and p21 in hP-MSCs exposed to hypoxia for 24, 48, or 72 h; D: Cyclin E1, cyclin A2, CDK2, and p21 expression levels normalized against glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Data are means ± SD (n = 3). aP < 0.05 and bP < 0.01.
- Citation: Feng XD, Zhu JQ, Zhou JH, Lin FY, Feng B, Shi XW, Pan QL, Yu J, Li LJ, Cao HC. Hypoxia-inducible factor-1α–mediated upregulation of CD99 promotes the proliferation of placental mesenchymal stem cells by regulating ERK1/2. World J Stem Cells 2021; 13(4): 317-330
- URL: https://www.wjgnet.com/1948-0210/full/v13/i4/317.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v13.i4.317